Here are the 10-K annual reports from AMERICA GREAT HEALTH (AAGH) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow AAGH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAGH filings page.
America Great Health reported modest growth but remains deeply unprofitable and financially stressed for the year ended June 30, 2025. Sales rose to $391,743 from $294,670 and gross profit doubled to $339,121, helped by lower cost of goods sold.
Operating expenses were $722,056, leading to a net loss of $721,242, narrower than the $1,226,362 loss a year earlier. Cash was only $44,056, with a working capital deficit of $3,584,235 and total shareholders’ deficit of $5,743,827, creating substantial doubt about the company’s ability to continue as a going concern.
The auditor issued a disclaimer of opinion on the 2025 and 2024 financial statements due to insufficient audit evidence over expenses, opening balances and the Purecell Group consolidation analysis. The company also reported material weaknesses in internal control, relies heavily on loans and advances from its majority shareholder, and its thinly traded OTC penny stock faces limited liquidity.